ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Erasca Inc

Erasca Inc (ERAS)

2.41
-0.11
(-4.37%)
Closed May 29 4:00PM
2.35
-0.06
(-2.49%)
After Hours: 6:04PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.35
Bid
2.35
Ask
2.59
Volume
10,425,788
2.31 Day's Range 2.53
1.51 52 Week Range 3.375
Market Cap
Previous Close
2.52
Open
2.50
Last Trade
71
@
2.46
Last Trade Time
Financial Volume
$ 25,409,811
VWAP
2.4372
Average Volume (3m)
1,334,234
Shares Outstanding
151,087,038
Dividend Yield
-
PE Ratio
-2.91
Earnings Per Share (EPS)
-0.83
Revenue
-
Net Profit
-125.04M

About Erasca Inc

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was $2.52. Over the last year, Erasca shares have traded in a share price range of $ 1.51 to $ 3.375.

Erasca currently has 151,087,038 shares outstanding. The market capitalization of Erasca is $364.12 million. Erasca has a price to earnings ratio (PE ratio) of -2.91.

ERAS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.352.91852.2951935972.56114726CS
40.3316.33663366342.022.91851.8127777052.29104413CS
120.073.07017543862.282.91851.7413342342.22816351CS
260.3517.522.91851.5113105472.08338897CS
52-0.45-16.07142857142.83.3751.519650722.22098178CS
156-13.55-85.220125786215.924.471.517821385.67957418CS
260-13.55-85.220125786215.924.471.517821385.67957418CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.9393
(129.10%)
576.2M
BNAIBrand Engagement Network Inc
$ 2.6062
(105.21%)
108.22M
ONCOOnconetix Inc
$ 0.2949
(79.93%)
137.82M
ASTSAST SpaceMobile Inc
$ 9.0199
(69.23%)
109.9M
KTRAKintara Therapeutics Inc
$ 0.272
(44.76%)
81.59M
FFIEFaraday Future Intelligent Electric Inc
$ 0.4379
(-62.57%)
417.92M
AWINAERWINS Technologies Inc
$ 5.555
(-39.22%)
2.01M
HLTHCue Health Inc
$ 0.0553
(-38.96%)
72.11M
GWAVGreenwave Technology Solutions Inc
$ 0.0494
(-37.15%)
676.15M
PLTNUPlutoniam Acquisition Corporation
$ 5.83
(-34.57%)
965
GWAVGreenwave Technology Solutions Inc
$ 0.0494
(-37.15%)
676.15M
LUCYInnovative Eyewear Inc
$ 0.9393
(129.10%)
576.2M
FFIEFaraday Future Intelligent Electric Inc
$ 0.4379
(-62.57%)
417.92M
RSLSReShape Lifesciences Inc
$ 0.2847
(37.01%)
212.55M
AALAmerican Airlines Group Inc
$ 11.62
(-13.54%)
159.16M

Your Recent History

Delayed Upgrade Clock